Indiana University School of Medicine, Indianapolis, Indiana, USA; Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Indiana University School of Medicine, Indianapolis, Indiana, USA.
Gastrointest Endosc. 2014 Feb;79(2):289-96. doi: 10.1016/j.gie.2013.08.006. Epub 2013 Oct 1.
Endoscopic papillectomy is increasingly used as an alternative to surgery for ampullary adenomas and other noninvasive ampullary lesions.
To measure short-term safety and efficacy of endoscopic papillectomy, define patient and lesion characteristics associated with incomplete endoscopic resection, and measure adenoma recurrence rates during long-term follow-up.
Retrospective cohort study.
Tertiary-care academic medical center.
All patients who underwent endoscopic papillectomy for ampullary lesions between July 1995 and June 2012.
Endoscopic papillectomy.
Patient and lesion characteristics associated with incomplete endoscopic resection and ampullary adenoma-free survival analysis.
We identified 182 patients who underwent endoscopic papillectomy, 134 (73.6%) having complete resection. Short-term adverse events occurred in 34 (18.7%). Risk factors for incomplete resection were jaundice at presentation (odds ratio [OR] 0.21; 95% confidence interval [CI] 0.07-0.69; P = .009), occult adenocarcinoma (OR 0.06; 95% CI, 0.01-0.36; P = .002), and intraductal involvement (OR 0.29; 95% CI, 0.11-0.75; P = .011). The en bloc resection technique was strongly associated with a higher rate of complete resection (OR 4.05; 95% CI, 1.71-9.59; P = .001). Among patients with ampullary adenoma who had complete resection (n = 107), 16 patients (15%) developed recurrence up to 65 months after resection.
Retrospective analysis.
Jaundice at presentation, occult adenocarcinoma in the resected specimen, and intraductal involvement are associated with a lower rate of complete resection, whereas en bloc papillectomy increases the odds of complete endoscopic resection. Despite complete resection, recurrence was observed up to 5 years after papillectomy, confirming the need for long-term surveillance.
内镜乳头切开术作为一种替代手术的方法,已越来越多地用于治疗壶腹腺瘤和其他非侵袭性壶腹病变。
测量内镜乳头切开术的短期安全性和疗效,确定与内镜下不完全切除相关的患者和病变特征,并测量长期随访期间的腺瘤复发率。
回顾性队列研究。
三级保健学术医疗中心。
1995 年 7 月至 2012 年 6 月间所有接受内镜乳头切开术治疗壶腹病变的患者。
内镜乳头切开术。
与内镜下不完全切除和壶腹腺瘤无复发生存分析相关的患者和病变特征。
我们共确定了 182 例接受内镜乳头切开术的患者,其中 134 例(73.6%)为完全切除。短期不良事件的发生率为 34 例(18.7%)。不完全切除的危险因素包括就诊时黄疸(优势比[OR]0.21;95%置信区间[CI]0.07-0.69;P=0.009)、隐匿性腺癌(OR 0.06;95%CI,0.01-0.36;P=0.002)和管内受累(OR 0.29;95%CI,0.11-0.75;P=0.011)。整块切除技术与更高的完全切除率密切相关(OR 4.05;95%CI,1.71-9.59;P=0.001)。在接受完全切除的壶腹腺瘤患者(n=107)中,16 例(15%)在切除后 65 个月内复发。
回顾性分析。
就诊时黄疸、切除标本中的隐匿性腺癌和管内受累与不完全切除的发生率较低相关,而整块乳头切除术增加了完全内镜切除的几率。尽管完全切除,但在乳头切除术后 5 年内仍观察到复发,证实需要长期监测。